Lepercq De Neuflize Asset Management LLC 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 10:46 am Purchase | 2023-12-18 | 13G | Bellerophon Therapeutics, Inc. BLPH | Lepercq De Neuflize Asset Management LLC | 1,026,868 8.400% | 1,026,868 (New Position) | Filing |